MCL coexpression mm9:1244: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0043565;sequence-specific DNA binding;0.00128041237870629;15395,13982,15396!GO:0003700;transcription factor activity;0.004...") |
No edit summary |
||
Line 1: | Line 1: | ||
{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0043565;sequence-specific DNA binding;0.00128041237870629;15395,13982,15396!GO:0003700;transcription factor activity;0.00425779343150948;15395,13982,15396!GO:0009653;anatomical structure morphogenesis;0.00745703692690638;15395,13982,15396!GO:0045839;negative regulation of mitosis;0.00821737696392652;13982!GO:0007389;pattern specification process;0.00916575112443743;15395,15396!GO:0006355;regulation of transcription, DNA-dependent;0.00916575112443743;15395,13982,15396!GO:0006351;transcription, DNA-dependent;0.00916575112443743;15395,13982,15396!GO:0032774;RNA biosynthetic process;0.00916575112443743;15395,13982,15396!GO:0003677;DNA binding;0.00916575112443743;15395,13982,15396!GO:0045449;regulation of transcription;0.00916575112443743;15395,13982,15396!GO:0048856;anatomical structure development;0.00916575112443743;15395,13982,15396!GO:0019219;regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00916575112443743;15395,13982,15396!GO:0006350;transcription;0.00916575112443743;15395,13982,15396!GO:0010468;regulation of gene expression;0.0093978923010452;15395,13982,15396!GO:0031323;regulation of cellular metabolic process;0.00961506158071779;15395,13982,15396!GO:0005667;transcription factor complex;0.00961506158071779;15395,15396!GO:0019222;regulation of metabolic process;0.0097359320341928;15395,13982,15396!GO:0016070;RNA metabolic process;0.00994272197671441;15395,13982,15396!GO:0001759;induction of an organ;0.00997226994819038;15396!GO:0010092;specification of organ identity;0.00997226994819038;15396!GO:0009887;organ morphogenesis;0.00997226994819038;15395,15396!GO:0045168;cell-cell signaling during cell fate commitment;0.00997226994819038;15396!GO:0031128;induction;0.00997226994819038;15396!GO:0044451;nucleoplasm part;0.00997226994819038;15395,15396!GO:0005654;nucleoplasm;0.0105053104482289;15395,15396!GO:0010467;gene expression;0.0117982004492543;15395,13982,15396!GO:0003676;nucleic acid binding;0.0122037722687037;15395,13982,15396!GO:0032502;developmental process;0.0127500285248328;15395,13982,15396!GO:0031981;nuclear lumen;0.0127500285248328;15395,15396!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0137472389941103;15395,13982,15396!GO:0007088;regulation of mitosis;0.0142119381120271;13982!GO:0031974;membrane-enclosed lumen;0.0142119381120271;15395,15396!GO:0043233;organelle lumen;0.0142119381120271;15395,15396!GO:0050794;regulation of cellular process;0.0149611027976701;15395,13982,15396!GO:0050789;regulation of biological process;0.0200777394008583;15395,13982,15396!GO:0001656;metanephros development;0.0201764519006285;15396!GO:0005496;steroid binding;0.0201764519006285;13982!GO:0003707;steroid hormone receptor activity;0.0201764519006285;13982!GO:0004879;ligand-dependent nuclear receptor activity;0.0201764519006285;13982!GO:0044428;nuclear part;0.0205358236401176;15395,15396!GO:0065007;biological regulation;0.0229268067524417;15395,13982,15396!GO:0005634;nucleus;0.0238045419967062;15395,13982,15396!GO:0043283;biopolymer metabolic process;0.025483047988348;15395,13982,15396!GO:0001822;kidney development;0.027160817266496;15396!GO:0001655;urogenital system development;0.0287305713925266;15396!GO:0048513;organ development;0.0325860332208126;15395,15396!GO:0016049;cell growth;0.0327041000229519;13982!GO:0045165;cell fate commitment;0.0340555540588183;15396!GO:0008361;regulation of cell size;0.0352516481138001;13982!GO:0005515;protein binding;0.0352516481138001;15395,13982,15396!GO:0045786;negative regulation of progression through cell cycle;0.0371480088490407;13982!GO:0043234;protein complex;0.03962013826808;15395,15396!GO:0048731;system development;0.0425824276148522;15395,15396!GO:0003002;regionalization;0.0443845586634856;15396!GO:0043170;macromolecule metabolic process;0.0451761693242856;15395,13982,15396!GO:0007067;mitosis;0.0482831052960478;13982!GO:0000087;M phase of mitotic cell cycle;0.0482831052960478;13982!GO:0000074;regulation of progression through cell cycle;0.0496525167121281;13982!GO:0001501;skeletal development;0.0496525167121281;15396!}} | {{MCL_coexpression_mm9 | ||
|coexpression_dpi_cluster_scores_mean=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.468810951402817,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0111309898120793,0,0,0,0,0,0,0,0.0457421522525172,0,0.0317518424311083,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.139092637649875,0.244595961508259,0.165248047545539,0,0,0,0,0,0.356679314741001,0.307616679637004,0,0,0,0,0.00869811735157467,0,0,0,0,0,0,0.0102922179483632,0.39853536447891,0.491946602877576,0.42584706310329,0,0.0105464367459272,0,0,0,0,0,0,0.110599436096358,0.188528732259936,0.122284614798021,0.146513963861889,0,0.0920409710752248,0,0,0,0,0,0.118808011695809,0,0,0.0878790634259986,0.0192387650524658,0.131630261678882,0,0.0466704488455586,0.00856829614165247,0.428374285964944,0.026081331947918,0,0.195492896508995,0.097060350309906,0.154094460964877,0.228480260119283,0,0,0,0,0,0,0.018967241077451,0,0,0,0.0164818733780083,0,0,0.737178910723469,0.234397092294514,0.016309161233149,0,0,0,0,0,0,0,0,0,1.09785023116919,0.855119442611945,0.866420878789601,0.727652941305435,0.728812882671012,0.508247053220969,0.540707114826968,0.292791171211265,0,0,0,0.0136254203921497,0.0152500436695449,0,0,0,0,0,0,0,0,0,0,0,0.0143666085988154,0,0,0,0,0.033967285130882,0.400189449448965,0.3187214237052,0.220553408278104,0.145704592617229,0.142102772886998,0.209036012991248,0,0.10579402103805,0.265261501055835,0.260041296466471,0.236450810429648,0,0.249902786279707,0.260035414670979,0.954560978491945,0.780285520047849,0.810456153520813,0.765518798541372,0.74373438210103,0.685023132192468,0.708052751081334,0.342357888020756,0.380375234615931,0.341672957885554,0,0,0.0129890193201731,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0125602184568965,0.0109277726371718,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.104974676366518,0,0,0,0,0,0,0,0,0,0,0.484339908017807,0.918157830659299,0.978636538134867,1.38512467893755,0,0,0,0,0.0187285000299395,0.0346896076909302,0,0,0,0,0,0,0.0719528621386508,0.0582152336478528,0,0,0,0,0.0110262957459347,0,1.60175381536208,0.875616757131044,0.444332355237358,0.0290903419121132,0.146060423245323,0.116118545397538,0.124818800630638,0.111457224789475,0,0.0922387155006588,0,0.0135811001783894,0,0,0.009273942432869,0,0.0113629758435916,0,0,0,0.10232706763359,0.161326104373072,0,0,0,0.00915732535949133,0,0,0.362806839347608,0,0,0.0100858711413906,0.0332484050430722,0.0257228022853725,0.0477321896759112,0.0112997018439347,0.12549549150626,0.298619738121252,0.0144356643696644,0,0,0,0.0133610693509637,0,0,0,0,0,0,0,0,0,0.00673131024600907,0,0,0,0,0.0172516782248752,0.0112333229753319,0.696667936582203,1.58692967303083,1.26958775587664,0.724371940448675,0.41208407202185,0,0,0,0,0,0,0,0,0,0,0.441369263484612,0.319028615991865,0.3169710988747,0.241416589846291,0.277700078054385,0.190574281876271,0.160610709512668,0.120446083158575,0.109249240335887,0.160208422740209,0.147383618249096,0.088876504789783,0.190549589696283,0.203573636596675,0.1838871158731,0.250696077142614,0.168130794925726,0.177664492583089,0.266543668146463,0.172858900395307,0.140024998598594,0.173512987665772,0.199302544705124,0.206736602805934,0.230431039063871,0.171410279467435,0.134144686192592,0.176831880222325,0.191444743645688,0.168187600283249,0.205529452154477,0.143956189592825,0.209249532809908,0.153868910714321,0.227917069276798,0,0.20896427015246,0.227931157606161,0.255723986815329,0.197970583803891,0.202799952191475 | |||
|gostat_on_MCL_coexpression=GO:0043565;sequence-specific DNA binding;0.00128041237870629;15395,13982,15396!GO:0003700;transcription factor activity;0.00425779343150948;15395,13982,15396!GO:0009653;anatomical structure morphogenesis;0.00745703692690638;15395,13982,15396!GO:0045839;negative regulation of mitosis;0.00821737696392652;13982!GO:0007389;pattern specification process;0.00916575112443743;15395,15396!GO:0006355;regulation of transcription, DNA-dependent;0.00916575112443743;15395,13982,15396!GO:0006351;transcription, DNA-dependent;0.00916575112443743;15395,13982,15396!GO:0032774;RNA biosynthetic process;0.00916575112443743;15395,13982,15396!GO:0003677;DNA binding;0.00916575112443743;15395,13982,15396!GO:0045449;regulation of transcription;0.00916575112443743;15395,13982,15396!GO:0048856;anatomical structure development;0.00916575112443743;15395,13982,15396!GO:0019219;regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00916575112443743;15395,13982,15396!GO:0006350;transcription;0.00916575112443743;15395,13982,15396!GO:0010468;regulation of gene expression;0.0093978923010452;15395,13982,15396!GO:0031323;regulation of cellular metabolic process;0.00961506158071779;15395,13982,15396!GO:0005667;transcription factor complex;0.00961506158071779;15395,15396!GO:0019222;regulation of metabolic process;0.0097359320341928;15395,13982,15396!GO:0016070;RNA metabolic process;0.00994272197671441;15395,13982,15396!GO:0001759;induction of an organ;0.00997226994819038;15396!GO:0010092;specification of organ identity;0.00997226994819038;15396!GO:0009887;organ morphogenesis;0.00997226994819038;15395,15396!GO:0045168;cell-cell signaling during cell fate commitment;0.00997226994819038;15396!GO:0031128;induction;0.00997226994819038;15396!GO:0044451;nucleoplasm part;0.00997226994819038;15395,15396!GO:0005654;nucleoplasm;0.0105053104482289;15395,15396!GO:0010467;gene expression;0.0117982004492543;15395,13982,15396!GO:0003676;nucleic acid binding;0.0122037722687037;15395,13982,15396!GO:0032502;developmental process;0.0127500285248328;15395,13982,15396!GO:0031981;nuclear lumen;0.0127500285248328;15395,15396!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0137472389941103;15395,13982,15396!GO:0007088;regulation of mitosis;0.0142119381120271;13982!GO:0031974;membrane-enclosed lumen;0.0142119381120271;15395,15396!GO:0043233;organelle lumen;0.0142119381120271;15395,15396!GO:0050794;regulation of cellular process;0.0149611027976701;15395,13982,15396!GO:0050789;regulation of biological process;0.0200777394008583;15395,13982,15396!GO:0001656;metanephros development;0.0201764519006285;15396!GO:0005496;steroid binding;0.0201764519006285;13982!GO:0003707;steroid hormone receptor activity;0.0201764519006285;13982!GO:0004879;ligand-dependent nuclear receptor activity;0.0201764519006285;13982!GO:0044428;nuclear part;0.0205358236401176;15395,15396!GO:0065007;biological regulation;0.0229268067524417;15395,13982,15396!GO:0005634;nucleus;0.0238045419967062;15395,13982,15396!GO:0043283;biopolymer metabolic process;0.025483047988348;15395,13982,15396!GO:0001822;kidney development;0.027160817266496;15396!GO:0001655;urogenital system development;0.0287305713925266;15396!GO:0048513;organ development;0.0325860332208126;15395,15396!GO:0016049;cell growth;0.0327041000229519;13982!GO:0045165;cell fate commitment;0.0340555540588183;15396!GO:0008361;regulation of cell size;0.0352516481138001;13982!GO:0005515;protein binding;0.0352516481138001;15395,13982,15396!GO:0045786;negative regulation of progression through cell cycle;0.0371480088490407;13982!GO:0043234;protein complex;0.03962013826808;15395,15396!GO:0048731;system development;0.0425824276148522;15395,15396!GO:0003002;regionalization;0.0443845586634856;15396!GO:0043170;macromolecule metabolic process;0.0451761693242856;15395,13982,15396!GO:0007067;mitosis;0.0482831052960478;13982!GO:0000087;M phase of mitotic cell cycle;0.0482831052960478;13982!GO:0000074;regulation of progression through cell cycle;0.0496525167121281;13982!GO:0001501;skeletal development;0.0496525167121281;15396! | |||
}} |
Revision as of 11:21, 11 October 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:5636678..5636725,- | p6@Esr1 |
Mm9::chr6:52190656..52190667,- | p7@Hoxa10 |
Mm9::chr6:52190668..52190682,- | p3@Hoxa10 |
Mm9::chr6:52195747..52195762,- | p3@Hoxa11 |
Mm9::chr6:52195763..52195792,- | p2@Hoxa11 |
Mm9::chr6:52195795..52195825,- | p1@Hoxa11 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0043565 | sequence-specific DNA binding | 0.00128041237870629 |
GO:0003700 | transcription factor activity | 0.00425779343150948 |
GO:0009653 | anatomical structure morphogenesis | 0.00745703692690638 |
GO:0045839 | negative regulation of mitosis | 0.00821737696392652 |
GO:0007389 | pattern specification process | 0.00916575112443743 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.00916575112443743 |
GO:0006351 | transcription, DNA-dependent | 0.00916575112443743 |
GO:0032774 | RNA biosynthetic process | 0.00916575112443743 |
GO:0003677 | DNA binding | 0.00916575112443743 |
GO:0045449 | regulation of transcription | 0.00916575112443743 |
GO:0048856 | anatomical structure development | 0.00916575112443743 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00916575112443743 |
GO:0006350 | transcription | 0.00916575112443743 |
GO:0010468 | regulation of gene expression | 0.0093978923010452 |
GO:0031323 | regulation of cellular metabolic process | 0.00961506158071779 |
GO:0005667 | transcription factor complex | 0.00961506158071779 |
GO:0019222 | regulation of metabolic process | 0.0097359320341928 |
GO:0016070 | RNA metabolic process | 0.00994272197671441 |
GO:0001759 | induction of an organ | 0.00997226994819038 |
GO:0010092 | specification of organ identity | 0.00997226994819038 |
GO:0009887 | organ morphogenesis | 0.00997226994819038 |
GO:0045168 | cell-cell signaling during cell fate commitment | 0.00997226994819038 |
GO:0031128 | induction | 0.00997226994819038 |
GO:0044451 | nucleoplasm part | 0.00997226994819038 |
GO:0005654 | nucleoplasm | 0.0105053104482289 |
GO:0010467 | gene expression | 0.0117982004492543 |
GO:0003676 | nucleic acid binding | 0.0122037722687037 |
GO:0032502 | developmental process | 0.0127500285248328 |
GO:0031981 | nuclear lumen | 0.0127500285248328 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0137472389941103 |
GO:0007088 | regulation of mitosis | 0.0142119381120271 |
GO:0031974 | membrane-enclosed lumen | 0.0142119381120271 |
GO:0043233 | organelle lumen | 0.0142119381120271 |
GO:0050794 | regulation of cellular process | 0.0149611027976701 |
GO:0050789 | regulation of biological process | 0.0200777394008583 |
GO:0001656 | metanephros development | 0.0201764519006285 |
GO:0005496 | steroid binding | 0.0201764519006285 |
GO:0003707 | steroid hormone receptor activity | 0.0201764519006285 |
GO:0004879 | ligand-dependent nuclear receptor activity | 0.0201764519006285 |
GO:0044428 | nuclear part | 0.0205358236401176 |
GO:0065007 | biological regulation | 0.0229268067524417 |
GO:0005634 | nucleus | 0.0238045419967062 |
GO:0043283 | biopolymer metabolic process | 0.025483047988348 |
GO:0001822 | kidney development | 0.027160817266496 |
GO:0001655 | urogenital system development | 0.0287305713925266 |
GO:0048513 | organ development | 0.0325860332208126 |
GO:0016049 | cell growth | 0.0327041000229519 |
GO:0045165 | cell fate commitment | 0.0340555540588183 |
GO:0008361 | regulation of cell size | 0.0352516481138001 |
GO:0005515 | protein binding | 0.0352516481138001 |
GO:0045786 | negative regulation of progression through cell cycle | 0.0371480088490407 |
GO:0043234 | protein complex | 0.03962013826808 |
GO:0048731 | system development | 0.0425824276148522 |
GO:0003002 | regionalization | 0.0443845586634856 |
GO:0043170 | macromolecule metabolic process | 0.0451761693242856 |
GO:0007067 | mitosis | 0.0482831052960478 |
GO:0000087 | M phase of mitotic cell cycle | 0.0482831052960478 |
GO:0000074 | regulation of progression through cell cycle | 0.0496525167121281 |
GO:0001501 | skeletal development | 0.0496525167121281 |
Relative expression of the co-expression cluster over median <br>Analyst:
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |